Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|4|1013-1023

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1013-1023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1013-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E146-E154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Viral Kinetics during Treatment of Chronic Hepatitis C Virus Infection with Pegylated Interferon Alpha plus Ribavirin in Taiwan

By  

Intervirology, Vol. 50, Iss. 4, 2007-07 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct‐acting antivirals has failed

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 129-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 63-69

Karger

Access to resources Recommend Favorite